Tolebrutinib

Based on the following article, this item was added to the Observatory page. > Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial Source [The Lancet](https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00237-4/fulltext)

Based on the following article, this item was added to the Observatory page.

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

Source The Lancet

This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by making a donation to pay for the server costs.

I want to donate now